Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

How should patients with, or at risk of, cardiovascular disease be screened for chronic kidney disease?

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Remuzzi G et al. (2006) Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 116: 288–296

    Article  CAS  Google Scholar 

  2. Asselbergs FW et al. (2004) Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation 110: 2809–2816

    Article  CAS  Google Scholar 

  3. Gaspari F et al. (1995) Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate. J Am Soc Nephrol 6: 257–263

    CAS  PubMed  Google Scholar 

  4. Ruggenenti P and Remuzzi G (2006) Time to abandon microalbuminuria? Kidney Int 70: 1214–1222

    Article  CAS  Google Scholar 

  5. Dirks JH et al. (2006) Meeting report on the Bellagio Conference 'prevention of vascular diseases in the emerging world: an approach to global health equity'. Kidney Int 70: 1397–1402

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giuseppe Remuzzi.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ruggenenti, P., Remuzzi, G. How should patients with, or at risk of, cardiovascular disease be screened for chronic kidney disease?. Nat Rev Nephrol 3, 126–127 (2007). https://doi.org/10.1038/ncpneph0406

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0406

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing